Parkside Financial Bank & Trust Amneal Pharmaceuticals, Inc. Transaction History
Parkside Financial Bank & Trust
- $772 Million
- Q1 2025
A detailed history of Parkside Financial Bank & Trust transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 65 shares of AMRX stock, worth $473. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65Holding current value
$473% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AMRX
# of Institutions
244Shares Held
137MCall Options Held
302KPut Options Held
103K-
Vanguard Group Inc Valley Forge, PA15.8MShares$115 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$89.8 Million3.16% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$82.1 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$78.2 Million2.58% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.49MShares$54.5 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.1B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...